By Donald Zuhn
Danisco A/S has announced that as a result of a finding of willful infringement by the District Court of Delaware, it would have to pay Novozymes A/S $8.2 million in damages, as well as a share of Novozymes' legal fees. Patent Docs reported on the Novozymes case last month (Defendant Genencor International is a Danisco subsidiary).
According to Danisco's press release, the company is currently assessing the District Court's decision and has reserved further comment. Danisco has until March 16th to appeal the District Court's decision.
Comments